Cochrane | Trusted evidence. Informed decisions. Better health.
Cochrane helps launch new WHO guidance on best practices for clinical trials. 8 October 2024. News. Cochrane Ireland and Cochrane Crowd empower citizen scientists in The People’s Review. 16 October 2024. News. World EBHC Day 2024 underscores the need for greater intersectoral collaboration to build resilient evidence ecosystems. 16 October 2024.
Oral painkillers available without prescription for acute pain
Non-prescription (over-the-counter, or OTC) analgesics (painkillers) are used frequently. They are available in various brands, package sizes, formulations, and dose. They can be used for a range of different types of pain, but this overview reports on how well they work for acute pain (pain of short duration, usually with rapid onset).
Duloxetine for treating painful neuropathy, chronic pain or
Duloxetine at 60 mg daily is effective in treating painful diabetic peripheral neuropathy in the short term, with a risk ratio (RR) for ≥ 50% pain reduction at 12 weeks of 1.73 (95% CI 1.44 to 2.08). The related NNTB is 5 (95% CI 4 to 7). Duloxetine at 60 mg daily is also effective for fibromyalgia over 12 weeks (RR for ≥ 50% reduction in ...
How accurate are rapid antigen tests for diagnosing COVID-19?
Accurate rapid diagnostic tests for SARS-CoV-2 infection would be a useful tool to help manage the COVID-19 pandemic. Testing strategies that use rapid antigen tests to detect current infection have the potential to increase access to testing, speed detection of infection, and inform clinical and public health management decisions to reduce transmission.
Our evidence - Cochrane
Cochrane publishes a wealth of material to support and guide your health decision making. Here are some selected resources: Cochrane Evidence Essentials - a free online resource offering an introduction to health evidence and how to use it to make informed health choices. Featured reviews - find out more about the latest featured Cochrane ...
Strategies for managing sexual dysfunction caused by ... - Cochrane
A wide range of management strategies are possible to address this problem, including behavioural, psychological and pharmacological approaches. 1. To determine the effectiveness of management strategies for sexual dysfunction caused by antidepressants. 2. To determine the adverse effects and acceptability of the different management strategies.
What are systematic reviews? - Cochrane
What are systematic reviews? Watch on. Cochrane evidence, including our systematic reviews, provides a powerful tool to enhance your healthcare knowledge and decision making. This video from Cochrane Sweden explains a bit about how we create health evidence and what Cochrane does. About Cochrane.
What are the benefits and risks of vaccines for preventing COVID …
Dec 7, 2022 · Key messages. – Most vaccines reduce, or probably reduce, the number of people who get COVID-19 disease and severe COVID-19 disease. – Many vaccines likely increase number of people experiencing events such as fever or headache compared to placebo (sham vaccine that contains no medicine but looks identical to the vaccine being tested).
How accurate are the Addenbrooke's Cognitive Examination III
There is insufficient information in terms of both quality and quantity to recommend the use of either the ACE-III or mini-ACE for the screening of dementia or MCI in patients presenting with, or at high risk of, cognitive decline.
Bupropion for attention deficit hyperactivity disorder (ADHD
Bupropion is registered for the treatment of depression and smoking cessation, but is also used off-label to treat ADHD. To assess the effects and safety of bupropion for the treatment of adults with ADHD. We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, and seven other databases in February 2017.